Merck Osteoporosis Drug Fosamax Responsible For Fractures
According to doctors at Weill Medical College of Cornell University, long-term use of Merck drug Fosamax (generic - bisphosphonate alendronate) could heighten the risk of fracture of the thigh bone, also referred to as the femur.
The contentions being promulgated by the experts is that prolonged use of alendronate may weaken bone metabolism thereby impeding the repair of small damage to the bones themselves, which increases the risk of fractures.
The study by Cornell involved a review of the femoral fractures of 70 patients admitted to their trauma center between 2002 and 2007. There are many in the medical, pharmaceutical and legal industries who believe that Merck knew about the defective nature of Fosamax, but did nothing about it.
If you or a loved one has been injured by the defective drug Fosamax and you would like info (information), help or assistance with the fallout, I would you to please visit my website, www.samlevine.com or contact my office, Sam Levine, Attorney at Law.
